If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYVE.L Regulatory News (HYVE)

  • There is currently no data for HYVE

Pre-Close Trading Update

28 Mar 2014 07:02

RNS Number : 4235D
ITE Group PLC
28 March 2014
 



 

28 March 2014

ITE Group plc

("ITE" or the "Group")

Interim results pre-close statement

ITE Group plc is today publishing a pre-close statement ahead of its interim results for the six months ended 31 March 2014 which will be announced on Monday 19 May 2014.

Trading

Revenue for the six month period to 31 March 2014 is estimated to be circa £72m, (six months to 31 March 2013: £69m). The revenue for this period reflects a stronger biennial pattern and good trading, off-set by negative currency movements. Like for like revenues over the first six months are 10% ahead of the prior year on a constant currency basis and 2% behind on an actual basis. These factors together with a first-time profit contribution from the recently acquired Chinacoat event which took place in November last year will help the Group produce record profits for the period.

Ukraine

The Group's exhibitions in Ukraine all take place in Kiev and to date the office has been able to run its exhibition calendar without putting the safety of staff or customers at risk. We continue to monitor the situation closely and are currently expecting to run the remaining events scheduled for this financial year. Sales for the Ukrainian business have been affected by the recent crisis, and we estimate that there will be a negative effect on the Group's profits of circa £2m this financial year, the majority of which will be reported in the second half of the year. During the full year ended 30 September 2013, Ukraine contributed 6% of Group revenue and 7% of Group profits.

Currency movements

As previously noted, the Group is exposed to movements in foreign currency exchange rates against Sterling for most of its overseas operations. The larger exposures are to the Euro, Ruble, Turkish Lira and the Kazakh Tenge which with the exception of the Euro, have all weakened significantly against Sterling during the period. If current exchange rates prevail for the remainder of the financial year, the Group estimates that the effect of translation differences on full year like for like revenues will be in the region of 13%, though the effect on profits is expected to be partly mitigated by natural currency hedging and partly by underlying growth in our revenue base.

Financial position

The Group's balance sheet remains strong with net debt of £4m at 26 March 2014, and facilities of £30m in place to 30 June 2015.

Outlook

As at 26 March 2014, the Group has contracted revenues of £146m for the full year which on a like-for-like basis is 4% less than this time last year. On a constant currency basis like for like revenues would be 8% ahead of revenues for this time last year. The Group continues to monitor the political uncertainty surrounding Ukraine and Russia, and the potential effect on sales in those countries. An update will be provided in the Interim results announcement.

Ends

 

Enquiries:

 

Russell Taylor, Chief Executive, ITE Group plc

Tel: 020 7596 5000

Neil Jones, Group Finance Director, ITE Group plc

Tel: 020 7596 5000

Charles Palmer/Emma Appleton, FTI Consulting

Tel: 020 3727 1000

James Serjeant, Numis Securities Ltd

Tel: 020 7260 1309

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGZFVRMGDZG
Date   Source Headline
6th Jun 201612:28 pmRNSHalf-year Report
6th Jun 201610:03 amRNSHolding(s) in Company
3rd Jun 201612:25 pmRNSHolding(s) in Company
31st May 20169:09 amRNSTotal Voting Rights
17th May 20167:00 amRNSResult of Secondary Placing
16th May 20164:38 pmRNSProposed secondary block placing in ITE Group PLC
9th May 20167:01 amRNSHalf-year Report
9th May 20167:00 amRNSAppointment of CEO
5th May 20167:00 amRNSBlock listing Interim Review
15th Apr 201612:45 pmRNSHolding(s) in Company
4th Apr 20167:00 amRNSTrading Statement
1st Apr 20169:36 amRNSHolding(s) in Company
22nd Mar 201612:07 pmRNSHolding(s) in Company
8th Feb 20164:52 pmRNSHolding(s) in Company
1st Feb 20169:36 amRNSSection 430(2B) Companies Act 2006 Statement
28th Jan 20164:01 pmRNSResults of AGM
28th Jan 20167:00 amRNSTrading Statement
22nd Jan 20169:28 amRNSDirector Declaration
14th Jan 201610:46 amRNSDirector/PDMR Shareholding
11th Jan 201610:22 amRNSDirector/PDMR Shareholding
18th Dec 20152:42 pmRNSNotice of AGM
1st Dec 20157:00 amRNSPreliminary Results Announcement
3rd Nov 20157:00 amRNSExercise of Call Option Over 31.7% of ABEC
23rd Oct 20154:10 pmRNSBlocklisting Interim Review
16th Oct 20157:01 amRNSDirectorate Change
1st Oct 20157:00 amRNSTrading Statement
30th Sep 201511:13 amRNSHolding(s) in Company
18th Sep 201511:46 amRNSHolding(s) in Company
9th Sep 20155:25 pmRNSCompany Secretary Appointment
14th Jul 20157:00 amRNSInterim Management Statement
10th Jul 20154:17 pmRNSHolding(s) in Company
2nd Jul 20154:56 pmRNSHolding(s) in Company
9th Jun 20153:51 pmRNSHolding(s) in Company
5th Jun 20151:30 pmRNSInterim Report 2015
14th May 20154:56 pmRNSTotal Voting Rights
14th May 20154:41 pmRNSHolding(s) in Company
13th May 20154:57 pmRNSHolding(s) in Company
12th May 20156:21 pmRNSDirector/PDMR Shareholding
12th May 20155:59 pmRNSDirector/PDMR Shareholding
11th May 20157:00 amRNSInterim Results Announcement
29th Apr 20155:25 pmRNSBlocklisting Interim Review
1st Apr 20157:00 amRNSInterim Results Pre-close Statement
31st Mar 20155:32 pmRNSHolding(s) in Company
17th Mar 20153:24 pmRNSHolding(s) in Company
12th Mar 20153:41 pmRNSHolding(s) in Company
11th Mar 20157:00 amRNSTotal Voting Rights
10th Mar 201510:44 amRNSHolding(s) in Company
6th Mar 20157:00 amRNSAcquisition and Placing
29th Jan 201512:58 pmRNSResult of AGM
29th Jan 20157:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.